In this review I will briefly survey the role of Pseudomonas aeruginosa, Acinetobacter baumanii, Stenotrophomonas maltophilia, and Burkholderia cepacia as opportunistic pathogens. A common feature of these organisms is intrinsic resistance to multiple antibiotics. All of these organisms can be recovered from the environment, commonly cause device-related infections, are often resistant to disinfectants, and have the potential to spread from patient to patient via fomites or the hands of medical personnel. Newer clinical syndromes will be emphasized, including the increasing importance of P. aeruginosa infections in patients with AIDS, as well as the role of carbapenems in selecting for A. baumanii and S. maltophilia and the unique niche of B. cepacia in patients with cystic fibrosis.
This brief review will examine some of the evolving clinical comparable to other recently published national data from the National Nosocomial Infection Surveillance (NNIS) survey issues posed by pathogenic, multiresistant, nonfermenting gram-negative bacilli. Prevalence rates, selected antimicrobial from the Centers for Disease Control and Prevention [2] . A large number of clinical and laboratory studies have conresistance rates, and newer clinical syndromes are emphasized. Separate articles elsewhere in this symposium will explore in firmed a relation between antibiotic exposure and emergence of antibiotic-resistant bacteria. For example, in a study of endetail the relevant mechanisms of resistance in these pathogens.
terobacter bacteremia, previous therapy with third-generation cephalosporins was shown to be responsible for resistance to Prevalence of Nonfermenters and Comparative b-lactams other than imipenem [3] . Similar data on the effect Resistance Rates in Hospitals of antibiotic exposure on resistance rates in P. aeruginosa exist. A significant correlation was noted in a single medical center The results of a survey of antibiotic susceptibilities of grambetween antecedent use of ceftizoxime, cefotaxime, ceftazinegative aerobes (33,869 organisms) from 396 intensive care dime, and piperacillin and resistance to these compounds in units in the United States, conducted from 1990 to 1993 [1] , bacterial strains that typically produce type 1 chromosomal bshowed that nationwide, Pseudomonas aeruginosa was the seclactamases, including 155 isolates of P. aeruginosa [4] . Simiond most common isolate after Escherichia coli and constituted larly, Manian and colleagues [5] analyzed resistance rates 19.7% of strains. The frequency of the other nonfermenters among 594 initial and repeated gram-negative isolates from discussed in this review were: Acinetobacter species, 5.3% of 287 patients in intensive care units (ICUs); 61% of these were isolates; Stenotrophomonas maltophilia, 3.7% of isolates; and Enterobacter and P. aeruginosa isolates. These investigators Burkholderia cepacia, õ1% of isolates. When the hospital reported that rates of resistance to cephalosporins and penicilbed number, teaching status, and body site of isolation were lins were significantly higher among repeated isolates and that analyzed, P. aeruginosa was the most frequent nonfermenter this resistance was statistically significantly linked to prior in teaching hospitals with ú500 beds and in respiratory specitreatment with a third-generation cephalosporin. mens. Factors associated with resistance to cephalosporins and penicillins included respiratory site, hospital bed number, and teaching status. Rates of recovery of P. aeruginosa remained stable throughout this period, with ceftazidime resistance ocClinical Problems Posed by Nonfermenters curring in Ç15% of isolates (table 1). In contrast, over the 4-P. aeruginosa. Historically, P. aeruginosa has been almost year study period, ceftazidime resistance rates increased among exclusively a nosocomial pathogen, causing infection in comKlebsiella species from 3.6% to 14.4% and among Enterobacpromised hosts in association with instrumentation and recent ter species from 30.8% to 38.3%. These resistance data are antibiotic exposure [6] . In the NNIS system, it is the fourth most common cause of nosocomial infection and the leading cause of hospital-acquired, particularly ventilator-associated, pneumonia [6] . Pseudomonas infections are characteristically ceptions of osteomyelitis of the foot complicating puncture While the traditional regimen of choice for treatment of P. aeruginosa infections has been the combination of an antiinjury [8] and invasive external otitis among diabetics [9] .
Patients with AIDS have been identified in recent years as pseudomonal penicillin plus an aminoglycoside, there is some experience with other compounds, including carbapenems a new group of patients at risk for community-acquired P. aeruginosa infection [10 -13]. Both adults and children, (usually in combination with an aminoglycoside) and quinolones. There are emerging data on the influence of this therapy especially infants, with AIDS have been reported to be at risk. Of six children whose ages ranged from 5 months to 11 years on resistance rates. Recent studies examining quinolone resistance rates, for example, have shown significant increases and who had P. aeruginosa bacteremia, four had a pulmonary source of the infection, and four had skin manifestations (a among P. aeruginosa and Acinetobacter isolates [15] . In the case of carbapenems, the dominant mechanism of rate that is much higher than that among patients without AIDS) [14] , and two died [10] . In a series of 28 episodes of P. aerugiresistance in P. aeruginosa is loss of the carbapenem-specific porin, OprD2 [16] . Gaynes and colleagues [17] reported a modnosa bacteremia among 21 adults with AIDS, 12 infections were community acquired, and only 28% of the patients were est increase in imipenem resistance among P. aeruginosa isolates from the NNIS survey that were collected between 1986 neutropenic [13]; 65% of the patients had received antibiotic therapy in the month before the onset of bacteremia. Sources and 1990 ; the rates were highest in ICUs, respiratory samples, and large teaching hospitals. In a recent survey of 1,182 isolates of infection were the lungs (12 cases), intravascular devices (nine cases), and the upper respiratory tract (five cases), includof P. aeruginosa from 16 North American centers, the carbapenems were the most active agents tested, with resistance ing sinusitis and malignant external otitis. Forty percent of cases were fatal, and, of survivors, 33% relapsed despite an rates of 12.5% for imipenem and 4.2% for meropenem [18] . A cautionary note is emerging from Japan, where carbapenems average duration of therapy of 18 days.
Other important observations from this study included a 50% dominate the parenteral b-lactam market. Senda and colleagues [19] have described a novel carbapenem-hydrolyzing b-lactaincidence of cavitary pulmonary infiltrates among the patients with pneumonia and a better outcome for patients receiving mase, Imi-1, from 132 clinical isolates (among 3,700 tested) from 17 Japanese hospitals. This enzyme is transferrable to two antibiotics rather than one: four of nine patients in the monotherapy group died, compared with four of 15 in the twoother gram-negative species on a large plasmid and has subsequently been detected in clinical isolates of Serratia marcesdrug group. Although the number of patients in that analysis is relatively small, the findings are similar to those from a cens and Klebsiella pneumoniae [20] . Acinetobacter species. The nomenclature of Acinetobacter study of 200 episodes of P. aeruginosa bacteremia, which demonstrated a higher survival rate among patients receiving an is still evolving. At present, seven species have been named. For routine clinical purposes, compromises in nomenclature aminoglycoside plus an antipseudomonal penicillin than among those receiving only one drug [7] . In studies of sinusitis due are commonly made, such as designating organisms as Acinetobacter calcoaceticus-baumanni complex, although such to P. aeruginosa in patients with AIDS, surgical debridement generally has been required for cure [11] .
''lumping'' may obsure epidemiological relationships. Most clinical laboratories can distinguish biovar anitratus from bioHowever, two recent reports described hospital outbreaks due to imipenem-resistant strains [32, 33] . var 1woff ii on the basis of oxidation or nonoxidation of glucose, respectively. In recent series, Acinetobacter baumanii has been An outbreak in New York was described after widespread use of ceftazidime and imipenem to eradicate epidemics due the most commonly detected species [21] , although some clinical reports simply refer to ''Acinetobacter species'' [22] .
to Klebsiella strains harboring extended-spectrum b-lactamases [34] and to susceptible strains of Acinetobacter. In this outLike P. aeruginosa, Acinetobacter species are ubiquitous in the environment. Some strains are tolerant of soap, and these break, 10 cases of infection due to imipenem-resistant A. baumanii occurred; these cases were mostly nosocomial pneumoorganisms are the most common gram-negative organisms to be isolated from the hands of medical personnel [23]; 25% of nia in a surgical ICU [32] . Results of pulsed-field gel electrophoresis of chromosomal DNA from these strains sughealthy outpatients have skin colonization [24] , and 7% are colonized in the pharynx [25] .
gested clonal spread. Of 30 drugs tested against these strains, the most active agent was ampicillin/sulbactam. The conditions Acinetobacter species are most notorious as an agent of nosocomial pneumonia. In one study, 45% of tracheostomy of nine of 10 patients treated with this compound for ú3 days improved clinically. sites were colonized [26] . In the hospital, risk factors for pneumonia include intubation, antibiotic exposure, and care in an S. maltophilia. This organism, previously known as Pseudomonas maltophilia and later as Xanthomonas maltophilia, is ICU [27] . A variety of device-related infections have been described, including nosocomial meningitis [28] .
a common commensal that is readily isolated from water, soil, and sewage. The significance of this organism in cultures is In a recent report of 52 episodes of acinetobacter bacteremia from a tertiary care medical center in North America, not always clear and may depend on the presence of patient risk factors. In a report from a general hospital in 1979, only all patients had significant underlying illnesses, and 43 of these episodes were nosocomially acquired [22] . Thirty-one six of 128 isolates were believed to be clinically significant [35] . On the other hand, a more recent study from a cancer patients had malignancies or had sustained major trauma or burns. In this study, appropriateness of antibiotic therapy center showed that 114 of 237 isolates were clinically significant [36] . did not correlate with outcome, while severity of underlying illness did; death rates were high among patients with burns Like other nonfermenters, S. maltophilia is intrinsically resistant to many common antibiotics (table 3) . Nearly all strains and cancer, while the patients who had sustained trauma, most of whom were young men, did well. Pneumonia was produce an unusual chromosomally encoded zinc-dependent b-lactamase that confers broad resistance to carbapenems and the most common primary source of infection among the cancer and trauma patients, whereas most of the patients with many other b-lactams [38, 39] . S. maltophilia also may be resistant to disinfectants. In a report from Australia, 69 cases burns had a wound source.
Community-acquired acinetobacter infections are relatively of nosocomial infection due to a contaminated disinfectant were documented [40] . uncommon, although an intriguing report from Darwin in the Northern Territory of Australia implicated this agent as the S. maltophilia is most often associated with pneumonia, especially (but not exclusively) among cystic fibrosis patients, cause of 10% of cases of community-acquired pneumonia, especially in alcoholics [29] . There is an interesting and unexbut may cause a wide variety of nosocomial infections [41] . The great majority of infections occur in the hospital setting, plained seasonality to acinetobacter infections in the Northern Hemisphere, where these infections are more common in the where risk factors have included underlying malignancy and the use of central venous catheters and broad-spectrum antibisummer months [21] . Acinetobacter infections may be more common in the tropics. Acinetobacter was the most common otic therapy [41] . A variety of agents have been implicated, especially imipenem. In a study from a cancer hospital, expoorganism to infect combat wounds during the Vietnam conflict [30] . In a multinational in vitro surveillance study of resistance sure to imipenem was 10 times more frequent among patients infected by S. maltophilia than among controls [42] . In a report patterns among gram-negative enteric bacilli from patients in ICUs that was conducted in 1996, the prevalence of Acinetofrom Wisconsin, S. maltophilia was the most common organism to cause infection following injuries associated with corn bacter species was more than twice as high among 1,500 gramnegative isolates from 15 ICUs in the Peoples Republic of harvesting machines [43] . In a prospective, multicenter observational study of 91 epiChina than among comparable pooled data form the United States (C. Bell-Dixon, personal communication).
sodes of S. maltophilia bacteremia, 78% of patients had underlying malignancies [44] . The most common source was a cenAntibiotic resistance is a major clinical problem in treating acinetobacter infections. In a recent study from Germany, multral venous catheter. Twenty percent of patients had local inflammation at a catheter site and/or positive cultures of a tidrug resistance was common [31] (table 2). In that report imipenem was uniformly effective, and most strains were susremoved device, while another 56% had no obvious primary source. Among this group, 84% had central venous catheters. ceptible to amoxicillin/clavulanate and amikacin; 94% of strains were resistant to ciprofloxacin. In most surveys, only
The crude death rate was 38%. As in the study of acinetobacter bacteremia referred to earlier, underlying host factors were the Ç5% of Acinetobacter strains are resistant to imipenem [1].
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07-21-98 11:07:08 cida UC: CID best predictors of outcome. Mortality was significantly associSeveral unusual manifestations of S. maltophilia infection have recently been described. In a report of 114 infections from ated with underlying malignancy, neutropenia, immunosuppressive therapy, and overall severity of illness. Patients a cancer center, 17 patients had mucocutaneous and/or softtissue infection, six had metastatic cellulitis consisting of skin received a variety of antibiotics, including trimethoprim-sulfamethoxazole, extended-spectrum cephalosporins, and ticarcilnodules with surrounding cellulitis, and one developed lesions consistent with ecthyma gangrenosum [36] . All of these palin/clavulanic acid. There was a trend toward higher rates of survival among patients treated with more than one active tients had neutropenia and leukemia and had received recent antibiotic therapy. Six patients developed mucocutaneous inagent. prevalence of B. cepacia in this population increased from 7% to 40% between 1970 and 1990 in some North American cystic Trimethoprim-sulfamethoxazole was the primary antibiotic used to treat these soft-tissue infections. The patients with metafibrosis centers [60] . How much of this apparent increase is due to the changing biology of cystic fibrosis, e.g., the longer static cellulitis fared poorly. Two of the six patients who recovered from neutropenia responded, while the four who remained life span of afflicted patients, and how much is secondary to greater awareness and better detection methods is unclear. For neutropenic died of persistent infection despite antibiotic therapy.
Five cases of biliary sepsis due to S. maltophilia have been example, in one early study, B. cepacia was seeded in sputum samples and was detected in only 31% of the cystic fibrosis described [45] . All of these cases occurred in patients who had hepatobiliary malignancy complicated by biliary obstruction center laboratories surveyed [61] . The epidemiology of B. cepacia is incompletely understood. and had undergone biliary instrumentation. Four patients had recently received antibiotics lacking activity against S. malRisk factors for colonization and subsequent infection in the hospital setting include receipt of humidifier or nebulizer treattophilia. Four patients responded to appropriate antibiotic therapy and biliary decompression. ment, and this organism has been isolated from cultures of nebulizers and other respiratory therapy equipment [62] . Recent Therapy for S. maltophilia infections is problematic because of the broad antibiotic resistance that typifies this organism studies with use of sophisticated molecular epidemiological techniques, including phenotypic and genomic typing systems, [37] . In a recent survey of 130 isolates, the most active agents were minocycline, trimethoprim-sulfamethoxazole, and ticarhave clearly demonstrated transmission between patients in both hospital and social settings [62, 63] . These studies emphacillin/clavulanic acid. Some investigational quinolones, including sparfloxacin, are significantly more active than ciprofloxasize that control measures designed to limit the spread of this organism among patients with cystic fibrosis must take into cin. There are some data suggesting that antibiotic prophylaxis patterns impact resistance. For example, in one institution, rates account the risk of transmission in social settings. Some strains appear to be more readily transmitted than of trimethoprim-sulfamethoxazole resistance rose when this agent was used for selective decontamination of the bowel and others. DNA typing studies, including pulsed-field gel electrophoresis, revealed a particular B. cepacia lineage referred to decreased when ciprofloxacin was substituted, while rates of resistance to the latter rose [37] .
as the Edinburgh-Toronto (ET) lineage (also known as the ET 12 intercontinental clone), which is widespread in the United B. cepacia infections and cystic fibrosis. This organism, formerly known as Pseudomonas cepacia, is a ubiquitous plant Kingdom (38% of strains) and appears to have unusually high potential for colonization and transmission [64] . pathogen that was first described by Burkholder [46] in 1950 as a cause of soft rot of onions. Although B. cepacia can be Recent advances in understanding the pathogenesis of cystic fibrosis have shed considerable light on the microbiology of isolated from environmental sources, including soil, water, and plants, detection rates are low, in the range of 1% -16% of this disorder. For example, P. aeruginosa has been shown to bind specifically to superficial glycolipids in respiratory epithesamples [47] . A few case reports have described serious infections, including bacteremic pneumonia [48] and invasive otitis, lial cells [65] . In the case of B. cepacia, outer membrane proteins have been shown to facilitate binding to respiratory epiin previously healthy hosts [49] . B. cepacia also is an important pathogen among patients with chronic granulomatous disease, thelial cells [66] . Adhesion to respiratory mucin by B. cepacia is associated with giant interwined fibers referred to as cable in whom it can cause life-threatening infections [50] . It is a rare cause of nosocomial infection, primarily among patients pili [67] . The gene responsible for cable pili, cbl, has been detected in the ET 12 clone but has not been uniformly detected with cancer [51, 52] . Like the other nonfermenters under discussion, B. cepacia grows well in aquatic environments and in all epidemic clones, suggesting that other bacterial and/or host factors need to be identified [64] . can contaminate disinfectant solutions, particularly aqueous quarternary ammonium compounds. An outbreak at an oncolMost colonized or infected patients with cystic fibrosis display a chronic course of gradual deterioration in their condiogy clinic resulted in 14 cases of bacteremia [52] . An investigation revealed contamination of a saline solution used to flush tions, consistent with the low virulence of B. cepacia. However, for Ç20% of patients, the infection has an aggressive course, central venous catheters.
The major importance of this organism lies in its role as an with fever, bacteremia, and death within 1 year. This has been called the ''cepacia syndrome'' [47] . Risk factors include older opportunistic agent of pneumonia in cystic fibrosis patients [53 -55] . The pathogenesis and microbiology of cystic fibroage, female gender, and more severe disease. In recent work a molecular correlate of this more aggressive syndrome has sis -related pulmonary infections have been reviewed recently [56 -58] . There is a typical progression of pulmonary pathogens been found. Clinical isolates from patients with more severe disease display greater binding to respiratory mucins [68] . in these patients, from Haemophilus influenzae and Staphylo-/ 9c54$$au12 07-21-98 11:07:08 cida UC: CID
